The risk of cutaneous mucormycosis associated with COVID‐19: A perspective from Pakistan

Sucharu Asri, Muhammad Rizwan Akram, Mohammad Mehedi Hasan, Fatima Muhammad Asad Khan, Nida Hashmi, Fareha Wajid and Irfan Ullah

International Journal of Health Planning and Management, 2022, vol. 37, issue 2, 1157-1159

Abstract: As a developing country, Pakistan reports a high burden of fungal diseases, of which cutaneous mucormycosis remains a prominent infection, presenting as a highly invasive disease with significant mortality. Apart from a high population of at‐risk individuals, multiple factors have precipitated an increment in mucormycosis cases in the country following the COVID‐19 pandemic. These include increased use of corticosteroids, immunosuppression following the viral infection, prolonged stays in the intensive care unit and sub‐optimal laboratory testing available in the country. This article aims to assess the potential implications of a mucormycosis epidemic on a healthcare system already strained under the COVID‐19 pandemic, and provides subsequent recommendations to weather the dual challenge of two deadly pathogens.

Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1002/hpm.3311

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:ijhplm:v:37:y:2022:i:2:p:1157-1159

Ordering information: This journal article can be ordered from
http://www.blackwell ... bs.asp?ref=0749-6753

Access Statistics for this article

International Journal of Health Planning and Management is currently edited by Calum Paton

More articles in International Journal of Health Planning and Management from Wiley Blackwell
Bibliographic data for series maintained by Wiley Content Delivery ().